Asset Dedication, LLC Bristol Myers Squibb CO Transaction History

Asset Dedication, LLC

  • $1.46 Billion
  • Q3 2024

A detailed history of Asset Dedication, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Asset Dedication, LLC holds 6,446 shares of BMY stock, worth $382,054. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,446
Previous 7,687 16.14%
Holding current value
$382,054
Previous $319,000 4.39%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
SELL
$39.66 - $51.75 $49,218 - $64,221
-1,241 Reduced 16.14%
6,446 $333,000
Q2 2024

Aug 06, 2024
SELL
$40.25 - $52.99 $118,174 - $155,578
-2,936 Reduced 27.64%
7,687 $319,000
Q1 2024

Apr 16, 2024
SELL
$47.98 - $54.4 $19,815 - $22,467
-413 Reduced 3.74%
10,623 $571,000
Q4 2023

Feb 08, 2024
SELL
$48.48 - $57.85 $341,105 - $407,032
-7,036 Reduced 38.93%
11,036 $563,000
Q3 2023

Nov 13, 2023
SELL
$57.89 - $64.73 $9,436 - $10,550
-163 Reduced 0.89%
18,072 $1.05 Million
Q2 2023

Aug 21, 2023
SELL
$63.71 - $70.74 $195,908 - $217,525
-3,075 Reduced 14.43%
18,235 $1.16 Million
Q1 2023

Apr 21, 2023
BUY
$65.71 - $74.53 $96,527 - $109,484
1,469 Added 7.4%
21,310 $1.48 Million
Q4 2022

Jan 19, 2023
SELL
$68.48 - $81.09 $39,581 - $46,870
-578 Reduced 2.83%
19,841 $1.43 Million
Q3 2022

Oct 27, 2022
BUY
$0.13 - $76.84 $2,654 - $1.57 Million
20,419 New
20,419 $1.46 Million
Q2 2022

Jul 19, 2022
SELL
$72.62 - $79.98 $1.43 Million - $1.57 Million
-19,668 Closed
0 $0
Q1 2022

Apr 21, 2022
BUY
$61.48 - $73.72 $218,930 - $262,516
3,561 Added 22.11%
19,668 $1.44 Million
Q4 2021

Jan 21, 2022
SELL
$53.63 - $62.52 $244,231 - $284,716
-4,554 Reduced 22.04%
16,107 $1 Million
Q3 2021

Oct 18, 2021
BUY
$59.17 - $69.31 $21,242 - $24,882
359 Added 1.77%
20,661 $1.22 Million
Q2 2021

Jul 21, 2021
BUY
$61.91 - $67.42 $293,329 - $319,435
4,738 Added 30.44%
20,302 $1.36 Million
Q1 2021

May 03, 2021
SELL
$59.34 - $66.74 $245,964 - $276,637
-4,145 Reduced 21.03%
15,564 $976,000
Q4 2020

Jan 28, 2021
BUY
$57.74 - $65.43 $136,786 - $155,003
2,369 Added 13.66%
19,709 $1.22 Million
Q3 2020

Oct 20, 2020
BUY
$57.43 - $63.64 $100,904 - $111,815
1,757 Added 11.28%
17,340 $1.04 Million
Q2 2020

Aug 24, 2020
BUY
$54.82 - $64.09 $53,504 - $62,551
976 Added 6.68%
15,583 $911,000
Q1 2020

May 05, 2020
BUY
$46.4 - $67.43 $162,956 - $236,814
3,512 Added 31.65%
14,607 $816,000
Q4 2019

Jan 31, 2020
BUY
$49.21 - $64.19 $86,560 - $112,910
1,759 Added 18.84%
11,095 $709,000
Q3 2019

Oct 17, 2019
BUY
$42.77 - $50.71 $216,330 - $256,491
5,058 Added 118.23%
9,336 $472,000
Q2 2019

Jul 23, 2019
SELL
$44.62 - $49.34 $40,961 - $45,294
-918 Reduced 17.67%
4,278 $194,000
Q1 2019

Apr 19, 2019
BUY
$45.12 - $53.8 $24,861 - $29,643
551 Added 11.86%
5,196 $247,000
Q4 2018

Feb 12, 2019
SELL
$48.76 - $63.23 $24,331 - $31,551
-499 Reduced 9.7%
4,645 $243,000
Q3 2018

Oct 26, 2018
SELL
$55.19 - $62.25 $13,300 - $15,002
-241 Reduced 4.48%
5,144 $318,000
Q2 2018

Aug 13, 2018
BUY
$50.53 - $62.98 $55,027 - $68,585
1,089 Added 25.35%
5,385 $297,000
Q1 2018

Apr 19, 2018
BUY
$59.92 - $68.98 $34,513 - $39,732
576 Added 15.48%
4,296 $271,000
Q4 2017

Jan 17, 2018
BUY
$59.94 - $65.35 $43,876 - $47,836
732 Added 24.5%
3,720 $229,000
Q3 2017

Oct 18, 2017
BUY
$55.23 - $63.74 $165,027 - $190,455
2,988
2,988 $189,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Asset Dedication, LLC Portfolio

Follow Asset Dedication, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Dedication, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Dedication, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email